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ABSTRACT
Genetic mutations underlying neurodegenerative disorders impair
ribosomal DNA (rDNA) transcription suggesting that nucleolar
dysfunction could be a novel pathomechanism in polyglutamine
diseases and in certain forms of amyotrophic lateral sclerosis/
frontotemporal dementia. Here, we investigated nucleolar activity in
pre-symptomatic digenic models of Parkinson’s disease (PD) that
model the multifactorial aetiology of this disease. To this end, we
analysed a novel mouse model mildly overexpressing mutant human
α-synuclein (hA53T-SNCA) in a PTEN-induced kinase 1 (PINK1/
PARK6) knockout background and mutant mice lacking both DJ-1
(also known as PARK7) and PINK1. We showed that overexpressed
hA53T-SNCA localizes to the nucleolus. Moreover, these mutants
show a progressive reduction of rDNA transcription linked to a
reducedmouse lifespan. By contrast, rDNA transcription is preserved
in DJ-1/PINK1 double knockout (DKO) mice. mRNA levels of the
nucleolar transcription initiation factor 1A (TIF-IA, also known as
RRN3) decrease in the substantia nigra of individuals with PD.
Because loss of TIF-IA, as a tool to mimic nucleolar stress, increases
oxidative stress and because DJ-1 and PINK1 mutations result in
higher vulnerability to oxidative stress, we further explored the
synergism between these PD-associated genes and impaired
nucleolar function. By the conditional ablation of TIF-IA, we blocked
ribosomal RNA (rRNA) synthesis in adult dopaminergic neurons in a
DJ-1/PINK1 DKO background. However, the early phenotype of
these triple knockout mice was similar to those mice exclusively
lacking TIF-IA. These data sustain a model in which loss of DJ-1 and
PINK1 does not impair nucleolar activity in a pre-symptomatic stage.
This is the first study to analyse nucleolar function in digenic PD
models. We can conclude that, at least in thesemodels, the nucleolus
is not as severely disrupted as previously shown in DA neurons from
PD patients and neurotoxin-based PD mouse models. The results
also show that the early increase in rDNA transcription and nucleolar
integrity may represent specific homeostatic responses in these
digenic pre-symptomatic PD models.
KEY WORDS: Nucleolus, Parkinson’s disease, Neuronal
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INTRODUCTION
The nucleolus is a controller of neuronal homeostasis and a central
regulator of the cellular stress response (Boulon et al., 2010).
Nucleolar activity is tightly linked to cellular well-being, as rRNA
synthesis decreases in response to adverse extracellular conditions,
including DNA damage, oxidative stress and neurotrophic
withdrawal (Hetman and Pietrzak, 2012). Accordingly, reduced
rDNA transcription and disruption of nucleolar integrity are
common to several neurodegenerative disorders (Grummt, 2013;
Parlato and Kreiner, 2013). Interestingly, mutant proteins and RNAs
may directly interfere with the RNA polymerase I machinery,
reducing the level of rDNA transcription in polyglutamine diseases,
including Huntington’s disease (HD) and in some forms of
amyotrophic lateral sclerosis and fronto-temporal dementia
(ALS/FTD) (Parlato and Bierhoff, 2015).
Impaired nucleolar activity and disrupted nucleolar integrity,
known as nucleolar stress, have also been reported in Parkinson’s
disease (PD) autopsies in dopaminergic (DA) neurons (Rieker et al.,
2011; Parlato and Liss, 2014). Notably, nucleolar stress is evident in
neurotoxin-based PD mouse models upon analysis of rDNA
synthesis and by the altered distribution of nucleolar proteins
(Rieker et al., 2011; Healy-Stoffel et al., 2013). We have previously
shown that induction of nucleolar stress in DA neurons leads to
progressive and selective degeneration of substantia nigra (SN),
impaired mitochondrial function and increased oxidative stress
linked to downregulation of the mammalian target of rapamycin
(mTOR) pathway (Rieker et al., 2011; Kreiner et al., 2013). The
observation that neuronal death is accelerated in the acute
neurotoxin-based N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP) model upon nucleolar stress revealed a mechanistic
crosstalk between impaired nucleoli and mitochondria (Rieker
et al., 2011).
Most PD cases are idiopathic, ∼10% of PD cases are Mendelian
inherited and about 27% of heritability has been recently estimated
(Mullin and Schapira, 2015). Several genetic mutations and risk
factors for PD have been identified, revealing shared and
converging pathophysiological pathways (Mullin and Schapira,
2015; Kumaran and Cookson, 2015; Duda et al., 2016).
Interestingly, a PD-linked mutant form of the DJ-1 (PARK7) gene
impaired maturation of rRNA in a cellular PD model upon
proteasome inhibition (Vilotti et al., 2012). Conditional ablation
of parkin (PRKN also known as PARK2) in DA neurons results inReceived 4 October 2016; Accepted 28 March 2017
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reduced level of precursor rRNA (pre-rRNA) transcripts and release
of nucleolar proteins in the nucleus, a sign of nucleolar stress (Kang
and Shin, 2015).
Despite the emerging evidence, the time- and cell-specific link
between genetic mutations accounting for PD and nucleolar activity
is still poorly investigated. To this end, mouse models based on PD
genetic mutations represent a very convenient tool to dissect
mechanisms underlying neuronal homeostasis in pre-symptomatic
PD stages, as in general they are not affected by neuronal death
(Dawson et al., 2010). DJ-1 and PINK1 (also known as PARK6) for
example are known to protect against oxidative stress and to regulate
mitochondrial function and clearance (Kim et al., 2005; Narendra
et al., 2010). Mutations in these genes cause autosomal recessive
early-onset PD; however compensatory mechanisms have been
reported in the knockout mice, in which DA neuronal survival is not
impaired, even in aged mutant mice (Pham et al., 2010; Glasl et al.,
2012). This lack of DA neurodegeneration is also observed in
transgenic mice overexpressing PD-related α-synuclein (SNCA)
point mutations, sustaining the hypothesis that PD is a multifactorial
neurodegenerative disorder (Dawson et al., 2010).
To focus the analysis on the integration of multiple pathways in
PD, we performed a systematic analysis of rDNA transcription and
nucleolar integrity in a novel digenic mouse model of PD. In this
model, the heterologous prion promoter drives an exclusively
neuronal overexpression (1.5-fold) of the PD-triggering human
A53T point mutation in SNCA (hA53T-SNCA) (Gispert et al.,
2003; Kurz et al., 2010). This mouse linewas named hA53T-SNCA,
and is also known as PrPmtA. In the double mutant mice, this mild
overexpression of hA53T-SNCA as a neurotoxic stressor is
complemented with a PTEN-induced kinase 1 knockout (PINK1KO)
background, leading to a loss of stress responses (hA53T-SNCA/
PINK1KO) at different stages (Gispert et al., 2015; Auburger et al.,
2016). hA53T-SNCA/PINK1KO mice showed a phenotype more
severe than each respective single mutant, in particular, spontaneous
activity at 3 months and lifespan were reduced, concomitantly with
altered degradation and aggregation of SNCA protein at 18 months
(Gispert et al., 2015). These characteristics were crucial when the
mouse line was chosen for this study.
In addition, we studied adult mutant mice lacking DJ-1 and
PINK1 (Pham et al., 2010; Glasl et al., 2012). DJ-1KO mice show
∼6% DA neuronal loss only in the ventral tegmental area
independent of age and slight alterations in exploratory/
motivational and cognitive behaviour (Pham et al., 2010). PINK1
KO mice show alterations in gait and olfactory function, but no
alterations in DA neuron survival examined at 6 and 19 months
(Glasl et al., 2012). Previous studies based on the triple knockout of
parkin, DJ-1 and PINK1 have also shown no effects on DA neuronal
survival, at least until 24 months (Kitada et al., 2009). These
combined genetic models were therefore suitable to investigate
the impact of PD-related genes on nucleolar function in pre-
symptomatic models independently of DA neuronal loss.
We showed that the hA53T-SNCA mutation in a PINK1 KO
background leads to reduced pre-rRNA levels and changes in
number of nucleoli, accompanied by the progression towards a more
severe phenotype. On the contrary, DJ-1 and PINK1 double
knockout mice do not show reduced levels of rRNA synthesis.
Because loss of DJ-1 and PINK1, and inhibition of rRNA synthesis
alter mitochondrial function and render DA neuronsmore vulnerable
to oxidative stress, we further investigated the functional link
between these PARK genes and impaired nucleolar activity, which is
known to increase oxidative stress (Rieker et al., 2011; Kreiner et al.,
2013). We induced nucleolar stress in adult mice by the conditional
genetic ablation of the RNA polymerase I regulator transcription
initiation factor-1A (TIF-IA) in the DJ-1/PINK1 double knockout
(DKO) background (Rieker et al., 2011). The phenotype of the
TIF-IA single mutants was not enhanced in the triple knockout mice,
further indicating that loss of DJ-1 and PINK1 does not regulate
nucleolar function in these mouse models of pre-symptomatic PD.
Taken together, these results support the role of nucleolar-
dependent mechanisms in the pre-symptomatic PD phase, and
reveal differential effects of PARK mutations on nucleolar activity
of SN DA neurons, as well as on homeostatic responses that target
nucleolar function in preclinical stages.
RESULTS
Nucleolar activity is altered in a pre-symptomatic PD model
based on mild overexpression of human A53T-SNCA in a
PINK1-null genetic background
In hA53T-SNCA/PINK1KO mice, behavioural abnormalities occur
at 3 months, while increased protein aggregates are visible in the
ventral midbrain between 15 and 17 months (Gispert et al., 2015)
and the lifespan of a subset of these mice is reduced starting from
16 months (Gispert et al., 2015). In light of these phenotypes and
because of the decreased viability after 16 months, we used 3-
month-old mice as the early stage, and mice aged 16 and 19 months
to represent the late stages in our analysis. By immunofluorescence
staining with a specific human anti-SNCA antibody, we confirmed
that hA53T-SNCA transgenic mice overexpress SNCA in the
cytoplasm and nucleus of ventral midbrain DA neurons identified by
tyrosine hydroxylase (TH) immunoreactivity at 3 months in
comparison with the wild type (Fig. 1; Fig. S1) (Gispert et al.,
2015). By the immunostaining with a nucleolin (NCL)-specific
antibody, to identify the nucleolus, we showed that although hA53T-
SNCA is completely absent in thewild-type DA neurons as expected
(Fig. 1A-C), it is located in the nucleus and in the nucleolus in DA
neurons of hA53T-SNCA/PINK1KO mice (Fig. 1D-F).
Next, to monitor rDNA transcription, we detected 47S pre-rRNA
(1-130) and another intermediate precursor (597-765) by
quantitative real-time PCR (qRT-PCR) in dissected ventral
midbrain at 3, 16 and 18 months in hA53T-SNCA/PINK1KO and
respective age-matched controls (Fig. 2A-C). By this approach, the
differences in pre-rRNA levels observed in hA53T-SNCA/
PINK1KO mice at 18 months (Fig. 2B,C; Fig. S2A,B) in
concomitance with a reduced lifespan and manifestation of the
symptomatic phase, were not significant. Given the heterogeneous
expression of the transgene across DA neurons and the different
neuron populations, to provide a deeper insight of the rate of rRNA
synthesis at the level of single DA cells, we performed in situ
hybridization (ISH) in combination with immunohistochemistry
(IHC) with anti-TH antibody and visualized full-length 47S pre-
rRNA in DA neurons of SN and ventral tegmental area (VTA) in
tissue sections (Fig. 2A,D,E). The stained area identifying the
nucleolar pre-rRNA signal was about 30% lower in hA53T-SNCA/
PINK1KO mice at 19 months of age in comparison to controls,
suggesting a decreased amount of 47S pre-rRNA selectively in VTA
DA neurons (Fig. 2E, right), but not SN DA neurons of hA53T-
SNCA/PINK1KO mice (Fig. 2E, right; Fig. S2C,D).
The initial description of the hA53T-SNCA transgenic mice with
exclusive neuronal expression driven by the prion promoter also
showed human SNCA immunoreactivity in the hippocampus
(Gispert et al., 2003). Accordingly, we also analysed 47S pre-
rRNA signals at late stages in this region; however, the differences
between the hA53T-SNCA/PINK1KO mutant and respective
control mice, were not significant (Fig. S3).
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A similar analysis performed at 3 months in DA neurons of
hA53T-SNCA/PINK1KO mice did not reveal any significant
changes of pre-rRNA (Fig. 2E, left). Interestingly, a quantitative
analysis of 47S pre-rRNA signals in DA neurons at 3 months
showed that the percentage of TH-positive neurons containing one
nucleolus was lower in SN and VTA of mutant mice (Fig. 3A;
Fig. S4A,B). Concomitantly, the percentage of DA neurons
showing no nucleolar staining increased (Fig. 3A). Nevertheless,
the percent of TH-positive neurons with more than one 47S signal
was also increased in the hA53T-SNCA/PINK1KO mutant mice,
suggesting that in a subset of DA neurons transcription of rDNAwas
promoted (Fig. 3A). These data were supported by IHC with NCL-
and nucleophosmin/B23 (NPM)-specific antibodies in combination
with TH immunostaining (Fig. 3B-D). Analysis of the distribution
of these two independent nucleolar markers in TH-positive neurons
showed that the number of neurons containing two or three nucleoli
was significantly higher in the hA53T-SNCA/PINK1KO mutant
mice (Fig. 3C,D; Fig. S4C-F). This pattern of staining might suggest
the activation of compensatory mechanisms promoting nucleolar
activity in young mice.
To further explore the hypothesis that reduced levels of 47S pre-
rRNA and altered nucleolar integrity at late stages could be linked to
reduced expression of rRNA synthesis regulators, we used qRT-
PCR to analyse the levels of Ncl and Npm1 (B23) mRNA, which
encode nucleolar proteins known to play a role in the regulation of
rRNA synthesis, in the ventral midbrain samples from hA53T-
SNCA/PINK1KO mice and age-matched controls at 3, 16 and
18 months (Fig. 3E and Fig. S4G,H). No differences were detected,
suggesting that impaired nucleolar activity detected by qRT-PCR
and by ISH was not linked to a general transcriptional deficit in the
ventral midbrain.
Interestingly, TIF-IA mRNA levels were significantly lower in
the ventral midbrain of human post-mortem PD brain samples
compared with those from age-matched controls (control, N=8 and
PD, N=5; Fig. 4A). These findings support previous evidence of
impaired rRNA synthesis in PD symptomatic stages (Kang and
Shin, 2015; Rieker et al., 2011); however, they need to be
interpreted with caution given the different cellular composition
of the human ventral midbrain tissue in control and PD patients. To
further investigate a link between PD-related mutations and
nucleolar activity in hA53T-SNCA/PINK1KO models, we
analysed the expression of TIF-IA in hA53T-SNCA/PINK1KO
mice. Similar to the human PD samples, TIF-IA mRNA in mouse
ventral midbrain tissue was reduced at a clearly symptomatic stage
(18 months) after a surprising transitory upregulation phase at
16 months (Fig. 4B; Fig. S5).
rDNA transcription is unaltered in a pre-symptomatic PD
model based on the genetic inactivation of DJ-1 and PINK1
Similarly, we analysed nucleolar activity in genetic models of
pre-symptomatic PD based on autosomal recessive PARK gene
mutations. Parkin mutant mice have been previously analysed
(Kang and Shin, 2015). Here, we focused on DJ-1/PINK1 DKO
mice and control littermates. By qRT-PCR analysis, levels of pre-
rRNA (1-130) and the intermediate precursor (597-765) were
similar in dissected ventral midbrain samples from adult control
Pink1−/− and in DKO mice (7 months old) (Fig. 5A; Fig. S6A).
The quantitative analysis of 47S pre-rRNA signal in DA neurons
after ISH in combination with TH immunostaining did not reveal a
decreased stained area in TH-positive neurons of the individual
single knockouts or DKO mice, further supporting the conclusion
that the loss of both DJ-1 and PINK1 did not impair rDNA
transcription (Fig. 5B,C). On the contrary, the stained area
identifying the nucleolar 47S signal in SN DA neurons of DKO
mice, was significantly larger than that of controls, while the other
differences did not reach statistical significance (Fig. 5C; Fig. S6B).
The analysis of Ncl, Npm and TIF-IA mRNA levels in ventral
midbrain from control, PINK1 KO and DJ-1/PINK1 DKO mice did
not show any significant difference (Fig. 5D; Fig. S6C). These
results indicate that pre-symptomatic PD models activate
Fig. 1. hA53T-SNCA is expressed in DA neurons in the
cytoplasm, the nucleus and the nucleolus.
Representative confocal microscopy images of paraffin
sections immunostained with TH (green), human SNCA
(α-syn; red)- and NCL (blue)-specific antibodies from
3-month-old wild-type (A-C) and hA53T-SNCA-
overexpressing transgenic mice in a PINK1 KO
background (hA53T-SNCA/PINK1KO) (D-F). B,C and E,F
show higher magnifications of the region indicated by the
arrows in A and D, respectively. Scale bar: 25 μm (A,D)
and 12 µm (B-F).
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compensatory transcriptional mechanisms maintaining RNA
polymerase I activity; however, symptomatic stages are, in
general, associated with disrupted nucleolar function and integrity
(Rieker et al., 2011).
Early PD-like phenotypes caused by loss of TIF-IA are not
enhanced by DJ-1/PINK1-dependent networks
These results indicated that unlike results seen with hA53T-SNCA/
PINK1KO and previously reported neurotoxin-based models
(Healy-Stoffel et al., 2013; Rieker et al., 2011), loss of DJ-1 and
PINK1 did not impair nucleolar activity in DA neurons.
The observation that DA-specific TIF-IA conditional KO mice
(cKO) are more vulnerable to acute MPTP treatment suggested the
interaction of nucleolar- and mitochondrial-dependent pathways in
these models of neurodegeneration (Rieker et al., 2011). Similarly,
because both DJ-1 and PINK1 play a neuroprotective role against
oxidative stress, we tested the hypothesis that DJ-1/PINK1 KO
could exacerbate the effects of nucleolar stress in DA neurons,
suggesting that the pathways regulated by DJ-1 and PINK1 interact
with those triggered by nucleolar stress.
To this end, we generated inducible DATIF-IA cKOmice lacking
DJ-1 and PINK1 (triple KO, TKO) and analysed mice at 3 months
Fig. 2. rDNA transcription levels and
reduced nucleolar area in DA
neurons of hA53T-SNCA/PINK1KO
mice at early symptomatic stages.
(A) Schematic representation of the
47S pre-rRNA transcript including the
positions of the riboprobe used for ISH,
primers used for qRT-PCR and the A′
and A0 cleavage sites within the 5′
external transcribed spacer (ETS).
(B,C) Analysis of pre-rRNA (1-130) and
pre-rRNA (597-765) by qRT-PCR at 3,
16 and 18 months in the ventral
midbrain of wild-type (N=8,3,3) and
hA53T-SNCA/PINK1KO mice
(N=6,3,3) expressed as fold change to
respective controls and normalized by
Gapdh. (D) Representative images of
ISH with 47S-specific riboprobe (blue)
in combination with IHC by a TH-
specific antibody (brown) at 19 months
in VTA and SN of wild-type and
hA53T-SNCA/PINK1KO mice.
(E) Quantification of the area occupied
by the 47S staining in hA53T-SNCA/
PINK1KO expressed as fold change
relative to respective controls in SN and
VTA at 3 and 19 months (N=4 and 3
mice, respectively). Data are mean±
s.e.m.; *P<0.05 in comparison to wild-
type mice, as determined by Student’s
unpaired t-test. Scale bar: 70 μm.
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and 7 weeks after tamoxifen injection, a stage at which no
significant neuronal death has yet occurred in the DA TIF-IA
cKO mice (Rieker et al., 2011) (Fig. 6A). First, we confirmed that
nucleolar integrity was disrupted in DA neurons of TIF-IA cKO and
TKO by confocal analysis of immunofluorescence staining with
NCL- and TH-specific antibodies (Fig. 6B). Similarly, we showed
that NCL distribution was unaltered in the DJ-1/PINK1 DKO mice.
Moreover, the induction of nucleolar stress in DA neurons was
Fig. 3. Nucleolar number is altered in hA53T-SNCA/PINK1KO mice at pre-symptomatic stages. (A) Quantification of nucleoli detected by ISH with 47S-
specific riboprobe in TH-positive neurons of 3-month-old wild-type and hA53T-SNCA/PINK1KOmice (N=4) in SN (left) and VTA (right) expressed as percentage
of TH-positive neurons with 1, 2-3 or no nucleoli (nuc). (B) Representative images of ventral midbrain paraffin sections from 3-month-old wild-type and
hA53T-SNCA/PINK1KO mice immunostained with NCL (brown)- and TH (blue)-specific antibodies. (C,D) Quantification of the number of nucleoli detected by
NCL (C) and NPM (D) immunostaining in TH-positive neurons of wild-type and hA53T-SNCA/PINK1KO mice in SN (top) and VTA (bottom) expressed as
percentage of TH-positive neurons with 1, 2-3 or no nucleoli (N=4 mice). (E) Analysis of Ncl (top) and Npm (bottom) mRNA levels by qRT-PCR at 3, 16 and
18 months in wild-type (N=5,3,3) and hA53T-SNCA/PINK1KO mice (N=6,3,3) expressed as fold change to respective controls and normalized by Tbp. All data
are mean±s.e.m.; *P<0.05; **P<0.01; ***P<0.001 in comparison to wild-type, as determined by two-way ANOVA followed by Sidak’s multiple comparison test.
Scale bar: 50 μm.
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confirmed by IHC showing increased p53 protein levels in TKO
mice (Fig. 6C), as p53 levels are known to increase as a result of
nucleolar stress (Rieker et al., 2011).
However, TH immunoreactivity in the striatum of cKO and TKO
micewas comparable, indicating that loss of DJ-1 andPINK1 does not
exacerbate the toxic effects of nucleolar stress (Fig. 6D,E; Fig. S7A).
These results were supported by the comparable levels of dopamine in
the striata of TIF-IA cKO and TKO mice measured by high-
performance liquid chromatography followed by electrochemical
detection (HPLC-ED) (Fig. 6F; Fig. S7B). In summary, the results for
the DKO and TKO indicate that loss of DJ-1 and PINK1 does not
impair nucleolar activity and integrity in a pre-symptomatic stage, in
stark contrast to the hA53T-SNCA/PINK1KO model.
DISCUSSION
Nucleolar stress is emerging as one important factor in
neurodegenerative diseases (Hetman and Pietrzak, 2012; Parlato
and Bierhoff, 2015). In general, for as yet unclear reasons, inhibition
of rRNA synthesis could be both neuroprotective and neurotoxic
(Kreiner et al., 2013). Our study shows a differential effect of PD-
related (PARK) genetic mutations on nucleolar activity. While
hA53T-SNCA/PINK1KO did affect nucleolar activity, knockout of
DJ1 (PARK7) and PINK1 (PARK6) did not. Our results also show
that nucleolar activity decreases with increased phenotypic severity,
reinforcing its role as a stress sensor. The localization of mutant
SNCA in the nucleoli of DA neurons of hA53T-SNCA/PINK1KO
mice suggests that this mutant protein may directly interfere with
regulators of the RNA polymerase I transcriptional machinery.
Because NCL is mainly localized in the dense fibrillar compartment
where transcription and processing of rDNA take place, these steps
of rRNA biogenesis might be altered in the hA53T-SNCA/
PINK1KO mice (Sirri et al., 2008; Berger et al., 2015). A similar
function is common to causative mutant proteins, for example, in
polyglutamine diseases (Parlato and Bierhoff, 2015; Tsoi et al.,
2012). However, based on this study, we cannot rule out the
possibility that the hA53T-SNCA mutation is responsible for the
altered nucleolar activity and integrity observed at 3 and 20 months.
Given the observation that the PINK1 KO mice do not show the
same phenotype as the hA53T-SNCA/PINK1KO double mutants,
the hA53T-SNCA mutation might account for the decreased levels
of pre-rRNA and reduced nucleolar area observed in the early
symptomatic stage (from 16 months on).
The major advantage of the models examined here is that they do
not show neurodegeneration, enabling us to dissect the impact of
specific PD mutations on nucleolar activity and integrity
independent of neuronal loss. Moreover, the experimental
approaches adopted here allowed us to characterize rRNA
synthesis in specific DA neurons at pre-symptomatic PD stages.
The altered distribution of nucleolar proteins such as NCL and
NPM in hA53T-SNCA/PINK1KO mice confirms that nucleolar
activity is downregulated and nucleolar integrity is disrupted at an
early stage in a subset of DA neurons. Intriguingly, in the meantime,
another group of DA neurons upregulate rRNA synthesis, as shown
by the increased number of nucleoli, supporting the hypothesis that
initial compensatory mechanisms target nucleolar activity. A similar
condition has been also reported in motor neurons in a murine
model of ALS in response to the disturbance of endoplasmic
reticulum proteostasis and in response to proteasome inhibition in
sensory ganglion neurons (Palanca et al., 2014; Riancho et al.,
2014). In this regard, we should mention that the hypertrophy of
cortical neurons and their nuclei and nucleoli in asymptomatic
Alzheimer’s disease may represent an early reaction to the presence
of neurotoxic Aβ or tau, or a compensatory mechanism that prevents
the progression of the disease into dementia (Iacono et al., 2008;
Riudavets et al., 2007). This is linked to local Aβ-induced metabolic
insults and neuronal death (Cohen et al., 2009). Our previous results
show that the neuroprotective deletion of Pten in adult DA neurons
also results in the increase of neuronal soma and nucleolar size
(Domanskyi et al., 2011). Future studies are necessary to establish
whether enhanced nucleolar activity at a pre-symptomatic stage is
neuroprotective or on the other hand might even actively contribute
to neurodegenerative pathways – with potential implications for
design of therapeutic strategies. The next fundamental question is in
fact to what extent a controlled downregulation of nucleolar
function could even be beneficial under cellular stress (Mayer and
Grummt, 2005). Hence, further studies are required to establish the
role of the significant decrease of 47S pre-rRNA observed in the
hA53T-SNCA/PINK1KO mice in VTA DA neurons. This
observation suggests a differential regulation of nucleolar activity
in more-resistant VTA DA neurons and highly vulnerable SN DA
neurons, which are the most exposed DA population in PD, in line
with the functional and metabolic differences between VTA and SN
neurons (Duda et al., 2016). Of course, this differential vulnerability
may simply be due to the heterologous prion promoter driving
differing overexpression levels of hA53T-SNCA in the two
Fig. 4. Expression of TIF-IA that regulates rRNA synthesis in PD patients
and hA53T-SNCA/PINK1KO mice. (A) TIF-IA expression in ventral midbrain
DA neurons in brain autopsies from PD patients (N=5, n=20 sections) and age-
matched controls (N=8, n=16 sections) expressed as fold change compared
with controls normalized by ENO2; *P=0.0192, as determined by Wilcoxon
rank sum test. Data are mean±s.e.m. (B) Analysis of TIF-IA expression by
qRT-PCR in 3-, 16- and 18-month-old wild-type (N=8,3,3) and hA53T-SNCA/
PINK1KO mice (N=6,3,3) expressed as fold change to respective controls
normalized by Tbp. Data are mean±s.e.m.; *P<0.05 in comparison to wild-type
mice, as determined by Student’s unpaired t-test.
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neuronal populations. However, we cannot link this reduced
nucleolar activity to a reduced neuronal survival in this model
given its reduced lifespan. Ultimately the decreased pre-rRNA
synthesis observed at the late stage in this model could be linked to
ageing and/or be a consequence of the severe synaptic deficits in
these mice (Johnson et al., 1998; Burke, 2010).
Future studies in other mouse models generated by a knock-in
approach and expressing different pointmutations in the humanSNCA
gene, such as A30P, that lead to familial PD forms, could provide
further help to define in detail the link between specific PDmutations
and nucleolar activity (Plaas et al., 2008; Antony et al., 2011).
Unlike dominant negative mutant forms of SNCA, DJ-1 and
PINK1 loss-of-function mutations do not impair rDNA
transcription in DA neurons. However, the DJ-1 L166P mutation
that results in misfolded DJ-1 proteins with gain-of function effects,
leads to an increase of rDNA transcription in SH-SY5Y cells upon
proteasome inhibition unlike the DJ-1 loss-of-function mutation,
which has no effect (Vilotti et al., 2012). Loss of DJ-1 has been
shown to induce fragmentation of mitochondria and to cause a
deficit in mitochondrial fusion, resulting in increased endogenous
oxidative stress (Pham et al., 2010). Similarly, loss of PINK1
influences cellular sensitivity to toxins, protecting against
Fig. 5. rDNA transcription is not reduced in PINK1 KO or DJ-1/PINK1 DKO mice. (A) Analysis of pre-rRNA (1-130) and pre-rRNA (597-765) by qRT-PCR in
controls (N=3), PINK1 KO (N=8) and DJ-1/PINK1 DKO mice (N=8) expressed as fold change to respective controls normalized by Gapdh. (B) Representative
images of ISH with a 47S-specific riboprobe (blue) in combination with immunohistochemistry with a TH-specific antibody (brown) in 9-month-old control,
PINK1 KO and DKO mice. (C) Quantification of the area occupied by the 47S staining in control, DJ-1KO, PINK1 KO and DKO mice expressed as fold
change relative to respective controls in SN and VTA (N=3 mice). (D) Analysis of Ncl, Npm and TIF-IA mRNA levels by qRT-PCR in wild-type (N=3), PINK1 KO
(N=8) and DJ-1/PINK1 DKO (N=8) mice at 9 months expressed as fold change to respective controls normalized by Tbp. All data are mean±s.e.m. *P<0.05
as determined by one-way ANOVA followed by Tukey’s multiple comparisons test. Scale bar: 50 μm.
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mitochondrial fragmentation (Glasl et al., 2012). Drosophila Pink1
mutants show global downregulation of translation, suggesting that
such cellular response compensates mitochondrial dysfunction by
limiting energy consumption. In fact enhanced translation through
S6 kinase activation significantly exacerbated Pink1 mutant
phenotypes, whereas reduction of translation suppressed the
phenotype (Liu and Lu, 2010). Based on the observation that loss
of TIF-IA results in downregulation of mTOR activity, impaired
mitochondrial activity and increased oxidative stress (Rieker et al.,
2011; Kreiner et al., 2013), we expected an exacerbated impact of
nucleolar stress in DA neurons lacking DJ-1/PINK1, in particular on
DA striatal projections and dopamine content. However, the results
of this study may indicate that DJ-1 and PINK1 function either
upstream or independently of the rRNA control pathway, or that
they trigger protective compensatory processes that lead to normal
nucleolar function at pre-symptomatic stages.
The current link between PD-related mutations and rDNA
synthesis regulators, such as NCL, NPM and TIF-IA is further
summarized in Table 1. The expression levels of NCL are
dramatically reduced in the SN of human PD subjects, compared
with controls (Caudle et al., 2009) as well as with those of TIF-IA,
and could account for the reduced rRNA synthesis in PD. NCL and
also NPM may play a role in rRNA synthesis and in neuronal
survival (Pfister and D’Mello, 2015), prompting us to also assume
Fig. 6. Loss of DJ-1 and PINK1 does
not exacerbate the toxic effects of
nucleolar stress in DA neurons.
(A) Experimental design.
(B) Representative confocal images
showing nucleolar integrity in DA neurons
by immunofluorescence staining with
NCL (red) and TH (green) antibodies in
control, DJ-1/PINK1 DKO, TIF-IA
conditional mutants (cKO) and TKOmice.
(C) Representative IHC images of p53
protein (brown) in TH-positive neurons
(blue) in control and TKO mice 7 weeks
after TAM injections. Neurons showing
increased p53 levels are indicated by
arrowheads. (D) Representative images
of striatal TH immunoreactivity on
vibratome sections of control, DJ-1/
PINK1 DKO, TIF-IA conditional mutants
(cKO) and TKOmice. (E) Quantification of
TH immunoreactivity in the striata of
control (N=5), DKO (N=3), cKO (N=4) and
TKO (N=5) mice. (F) Analysis of
dopamine content by HPLC-ED in the
striata of control (N=13), DKO (N=9), cKO
(N=4) and TKO (N=5) mice. Data are
mean±s.e.m.; *P<0.05; **P<0.01;
***P<0.001 as determined by one-way
ANOVA followed by Tukey’s multiple
comparison test. ww, wet weight; TAM,
tamoxifen. Scale bar: 30 μm (B),
50 μm (C) and 200 μm (D).
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an important role of nucleolin in PD by regulation of rRNA
synthesis. Evidence of reduced NPM in PD has been also recently
provided (Garcia-Esparcia et al., 2015). Interestingly, both DJ-1 and
SNCA associate with NCL; hence, an imbalance in this interaction
could also alter rRNA synthesis (Jin et al., 2007). We could not
detect any change in Ncl mRNA in any of the genetic pre-
symptomatic PD mouse models; however, NCL and SNCA
colocalize in hA53T-SNCA/PINK1KO, suggesting that NCL
could be responsible for the observed changes in rRNA synthesis
in these mutants through a yet to be elucidated mechanism. Further
studies should address whether these mechanisms targeting the
nucleolus occur in pre-symptomatic PD and in other genetic PD
models. Mostly, it will be important to establish whether and when
changes of nucleolar activity turn out to be fatal, what triggers them
and why they have a cell-specific impact.
Conditional loss of parkin in DA neurons has been shown to
downregulate rRNA synthesis (Kang and Shin, 2015). NPM and
NCL interact with PARIS (parkin interacting substrate, ZNF746)
and PARIS colocalizes with parkin in the nucleolus (Kang and Shin,
2015). Interestingly, overexpression of PARIS inhibits rRNA
synthesis resulting in ∼30% less pre-rRNA 3 months after
induction of the mutation. The same study shows that PARIS
protein levels increases also in PD patients and that 47S pre-rRNA is
reduced in the SN of PD patients.
There is growing evidence that DJ-1, PINK1 and parkin interact
with each other, in particular PINK1 phosphorylates and activates
parkin and DJ-1 physically interacts with the transcription factor
forkhead box O3A (FOXO3A), to activate the Pink1 promoter in
DJ-1 KO mouse embryonic fibroblasts (Requejo-Aguilar et al.,
2015). However, unlike parkin cKO mice, which show
neurodegeneration at later stages, and also unlike PD- and
neurotoxin-based models (Rieker et al., 2011; Garcia-Esparcia
et al., 2015), RNA polymerase I activity is not severely impaired in
hA53T-SNCA/PINK1KO, PINK1 KO or DJ-1/PINK1 DKO mice,
supporting the hypothesis that compensatory responses might
sustain nucleolar activity (Mullin and Schapira, 2015).
Understanding these complex mechanisms is a prerequisite for
novel neuroprotective strategies that are based on selective
modulation of nucleolar function.
MATERIALS AND METHODS
Ethical use of human material and animals
Procedures involving animal care were approved by the Committee on
Animal Care and Use (RegierungspräsidiumKarlsruhe, 35-9185.81/G- 180/
08) in accordance with the local Animal Welfare Act and the European
Communities Council Directives (2010/63/EU and 2012/707/EU). Human
post-mortem midbrain tissue blocks were provided by the German
BrainNet, grant no. GA 28).
Human samples
Detailed information on the 13 human post-mortem ventral midbrain tissues
from controls and PD brains can be found in Schlaudraff et al. (2014). Mean
age of controls (N=8) is 69±1.6 years and PD (N=5) is 78.2±1.3 years
(Braak stages 0, II, III, IV, V).
Mice
Dj1−/− and Pink1−/− mice in a C57Bl6/J background were generously
donated by DrWolfgangWurst (Helmholtz ZentrumMünchen, Neuherberg,
Germany) (Pham et al., 2010; Glasl et al., 2012). Homozygous TIF-IAflox/flox;
DATCreERT2 mutant mice were generated by crossing mice carrying the
TIF-IA floxed allele to the transgenic line DATCreERT2. TIF-IA+/flox;
DATCreERT2-positive micewere crossed again with TIF-IAflox/floxmice. The
analysis of the genotype was performed as previously described (Rieker
et al., 2011). These mice were crossed to DJ-1 and PINK1 double knockout
mice to obtain triple knockout mice that lack TIF-IA in DA neurons after
tamoxifen induction of CreERT2. To induce TIF-IA gene deletion in DA
neurons, 2-month-old mice were injected intraperitoneally with 1 mg
tamoxifen (TAM) twice a day for five consecutive days and were analysed
7 weeks after the last injection (Rieker et al., 2011). As controls, littermates
with wild-type allele for all genes also injected with tamoxifen were
examined. Both male and female mice were used for the experiments.
PrPmtA mice overexpressing the human A53T-SNCA mutation were
crossed with Pink1−/− mice, as previously described (Gispert et al., 2015).
For the experiments reported here, male and female mice were used.
Histological analysis
Mice were sacrificed by cervical dislocation and brains were immediately
dissected. For immunohistochemistry, one brain hemisphere was fixed in
4% paraformaldehyde overnight and paraffin embedded or sectioned on a
vibratome (50 µm thickness); paraffin-embedded samples were sectioned to
7 µm thick. Vibratome sections containing the striatum comprised between
Bregma +0.14 mm and −0.98 mm and paraffin sections from the midbrain
region comprised between Bregma −2.54 mm and −3.80 mm were used for
the analysis and incubated with primary antibodies overnight at 4°C.
Visualization of antigen-bound primary antibodies following antigen
retrieval (HK086-9K, Biogenex) was carried out using a biotinylated
secondary antibody together with the avidin-biotin system and the
Vector peroxidase kit (PK-6100, Vector Laboratories) using both
diaminobenzidine tablets (D4293, Sigma) and HistoGreen HRP-substrate
kit (E109, Vector) as a substrate. For immunofluorescence, Alexa 488
(A-21206), Alexa 594 (A-21207) and Alexa 647 (A-21448) (1:100, Thermo
Fisher Scientific) secondary antibodies were used. Primary antibodies for
immunostaining were: anti-α-synuclein (1:500, ab27766, Abcam), anti-
nucleolin (1:500, ab70493, Abcam), anti-nucleophosmin (1:100,
MAB4500, NPM/B23, Millipore), anti-tyrosine hydroxylase (1:500,
AB1542, Millipore), anti-p53 (1:400, NCL-p53-CM5p, Novocastra).
Non-radioactive in situ hybridization (ISH) was performed on paraffin
sections using a specific riboprobe hybridizing to regions in the leader
sequence of the pre-rRNA followed by IHC with TH antibody as previously
described (Rieker et al., 2011). The ISH signal was quantified by labelling
the riboprobe with digoxigenin. This produced a defined signal area
(approximately the size of nucleoli) that was used for quantification of the
nucleolar area by ImageJ software (Rieker et al., 2011). For confocal
analysis, images were acquired using a Leica SP8 system.
RNA isolation and qRT-PCR
Total RNAwas isolated from dissected mouse ventral midbrain in the region
comprised between Bregma −2.54 mm and −3.80 mm. Levels of Ncl, Npm,
TIF-IA mRNA and pre-rRNA were monitored by reverse transcription
followed by quantitative real-time PCR (qRT-PCR). Synthesis of cDNAwith
M-MLV reverse transcriptase (SuperScript III First Strand Synthesis
Supermix) (18080-400, Thermo Scientific) was primed with random
hexamers. For detection of pre-rRNA, either the first 130 nucleotides
relative to the transcription start site were amplified using the 5′-ACTGAC-
ACGCTGTCCTTTCC and 5′-GACAGCTTCAGGCACCGCGA primers or
a primer pair covering the first processing site was used: 5′-
Table 1. Summary of the link between PD, PD-associated genes and
rRNA synthesis based on present and previous work
Sporadic
PD
hA53T-
SNCA/
PINK1
KO
PINK1
KO
DJ-1/
PINK1
DKO
DJ-1
L166P
PRKN
cKO
TIF-IA ↓ ↓ = = n.d. n.d.
NPM ↓a = = = n.d. n.d.
NCL ↓b = = = n.d. n.d.
Pre-rRNA ↓c ↓ = = ↑d ↓c
↓, Reduced expression; =, no change; ↑, increased expression; n.d., not
determined. Results shown are from the current study unless indicated:
aGarcia-Esparcia et al., 2015; bCaudle et al., 2009; cKang and Shin, 2015;
dVilotti et al., 2012.
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CGTGTAAGACATTCCTATCTCG and 5′- GCCCGCTGGCAGAACGA-
GAAG. To amplify Gapdh, we used the following primers: 5′-CATGGC-
CTTCCGTGTTCCTA and 5′-GCGGCACGTCAGATCCA. pre-RNA
levels relative to Gapdh mRNA levels were determined using SYBR
Green chemistry (SYBR Green Mix, 04887352001, Roche) by a Light
Cycler 480 instrument (Roche), as previously described (Kiryk et al., 2013).
For each amplicon, serial dilutions of cDNA from the ventral midbrain were
included in each run to generate standard curves for relative quantification by
the Light Cycler 480 software. The relative changes in pre-rRNA expression
were normalized to Gapdh, as a reference gene, after checking its stable
expression. The analysis of themouse ventral midbrain cDNAwas performed
by a StepOnePlus instrument (Applied Biosystems). The following TaqMan
gene expression assays were used: TIF-IA (Mm01344420_m1), nucleolin
(Mm01290591_m1), nucleophosmin (Mm02391781_g1), and Tbp (TATA-
binding protein) (Mm00446973-m1) (Applied Biosystems/Life
Technologies). For the TaqMan assays, the ΔΔCT method was used to
normalize the mouse qRT-PCR data by the 2−ΔΔCT formula (Livak and
Schmittgen, 2001). The normalization was performed using the stably
expressed reference gene Tbp. Expression changes were calculated as a fold
change versus mean of respective control samples.
Total RNA from human post-mortem horizontal midbrain tissue
cryosections was analysed on an Applied Biosystems GeneAmp 7900HT
PCR instrument, as previously described (Gründemann et al., 2008, 2011;
Schlaudraff et al., 2014). The human TIF-IA (Hs00255800_m1) and the
ENO2 (Hs00157360_m1) TaqMan assays (Applied Biosystems) were used
for real-time qPCR, and expression levels were calculated using respective
standard curve data by the formula S[(Ct-Yintercept)/slope], where S is the serial
dilution factor of the standard curve. The data were calculated in respect to
ENO2 (neuron specific enolase), by using slopes of respective standard
curves over 4 magnitudes as described in detail in (Schlaudraff et al., 2014).
We have empirically proven that ENO2 mRNA is expressed at constant
levels in individual SN DA neurons (Liss et al., 2001).
HPLC-ED
The striatum between Bregma +0.14 mm and−0.98 mmwas dissected using
a mouse brain matrix and dopamine content was measured per mg of wet
weight (ww) by HPLC-ED, as previously described (Rieker et al., 2011).
Statistical analysis
Eight coronal paraffin sections (every fourth section) per mousewere analysed
within the ventral midbrain and hippocampus for ISH and IHC. ImageJ
software was used to measure the area occupied by the 47S signal for at least
150 nucleoli per mouse. For DA neurons, the total area of the nucleolar signal
per mouse was normalized to the number of TH-positive neurons in either SN
or VTA (at least 150 cells per mouse in SN and at least 150 cells per mouse in
VTA), in this way we obtained the average 47S signal area per cell per mouse.
The average area per mouse from at least three mice per genotype at each age
was used to calculate the average nucleolar area per genotype and age. The
average area per genotype was then plotted as fold change relative to the
average area of the respective control and the results are expressed as the mean
of the fold changes ±s.e.m. Individual data plots are included in Figs S2,S4-S7.
ImageJ was also used to measure TH immunoreactivity in the striatum in
vibratome sections (Rieker et al., 2011). All measurements were carried out at
least in triplicate as specified in the figure legends. Statistical significance of
the results was analysed by one-way or two-way ANOVA, followed by post
hoc tests for comparisons between multiple groups or by Student’s t-test for
comparisons between two groups of values, as indicated in figure legends,
using GraphPad Prism (GraphPad) or SPSS Statistics (IBM) software
packages. In all cases, P<0.05 was considered significant.
This article is part of a special subject collection ‘Neurodegeneration: fromModels to
Mechanisms to Therapies’, which was launched in a dedicated issue guest edited by
Aaron Gitler and James Shorter. See related articles in this collection at http://dmm.
biologists.org/collection/neurodegenerative-disorders.
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